A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

This week on Tech Byte we travel to the Vascular Institute of Chattanooga for Dr. Will Harris to show us a new tech they have to help treat Peripheral Arterial Disease (PAD) that is new to this end of ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...

According to the National Heart, Lung, and Blood Institute, nearly 10 million people aged 40 and older have Peripheral Artery ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for Vascular ...

STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.

There are some common early indicators that all is not well with your heart but many are subtle and can be easily missed ...